106 related articles for article (PubMed ID: 28876927)
1. Attenuation of Antioxidant Capacity in Human Breast Cancer Cells by Carbon Monoxide through Inhibition of Cystathionine β-Synthase Activity: Implications in Chemotherapeutic Drug Sensitivity.
Kawahara B; Moller T; Hu-Moore K; Carrington S; Faull KF; Sen S; Mascharak PK
J Med Chem; 2017 Oct; 60(19):8000-8010. PubMed ID: 28876927
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein.
Kawahara B; Ramadoss S; Chaudhuri G; Janzen C; Sen S; Mascharak PK
J Inorg Biochem; 2019 Feb; 191():29-39. PubMed ID: 30458366
[TBL] [Abstract][Full Text] [Related]
3. Reaction of carbon monoxide with cystathionine β-synthase: implications on drug efficacies in cancer chemotherapy.
Kawahara B; Sen S; Mascharak PK
Future Med Chem; 2020 Feb; 12(4):325-337. PubMed ID: 32031001
[TBL] [Abstract][Full Text] [Related]
4. Luteolin-loaded phytosomes sensitize human breast carcinoma MDA-MB 231 cells to doxorubicin by suppressing Nrf2 mediated signalling.
Sabzichi M; Hamishehkar H; Ramezani F; Sharifi S; Tabasinezhad M; Pirouzpanah M; Ghanbari P; Samadi N
Asian Pac J Cancer Prev; 2014; 15(13):5311-6. PubMed ID: 25040994
[TBL] [Abstract][Full Text] [Related]
5. [Interaction between endogenous cystathionine synthase/hydrogen sulfide and heme oxygenase-1/carbon monoxide systems during myocardial ischemic-reperfusion: experiment with rats].
Zhu JC; Shao JL; Ma H; Wang JK
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(45):3222-5. PubMed ID: 19171098
[TBL] [Abstract][Full Text] [Related]
6. Lanthionine synthetase C-like protein 1 interacts with and inhibits cystathionine β-synthase: a target for neuronal antioxidant defense.
Zhong WX; Wang YB; Peng L; Ge XZ; Zhang J; Liu SS; Zhang XN; Xu ZH; Chen Z; Luo JH
J Biol Chem; 2012 Oct; 287(41):34189-201. PubMed ID: 22891245
[TBL] [Abstract][Full Text] [Related]
7. Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells.
Manandhar S; Lee S; Kwak MK
Arch Pharm Res; 2010 May; 33(5):717-26. PubMed ID: 20512470
[TBL] [Abstract][Full Text] [Related]
8. Sulfur amino acid metabolism in doxorubicin-resistant breast cancer cells.
Ryu CS; Kwak HC; Lee KS; Kang KW; Oh SJ; Lee KH; Kim HM; Ma JY; Kim SK
Toxicol Appl Pharmacol; 2011 Aug; 255(1):94-102. PubMed ID: 21703291
[TBL] [Abstract][Full Text] [Related]
9. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
10. [Effect of decreased GSH on sensitivity of breast cancer cells to ADM].
Han XQ; Li ZH; Zhang JG; Jiang YD; Peng KJ; Wang LZ; Wang SR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):770-4. PubMed ID: 17953354
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
12. Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin-transferrin conjugate.
Szwed M; Kania KD; Jozwiak Z
Biochimie; 2014 Dec; 107 Pt B():358-66. PubMed ID: 25312849
[TBL] [Abstract][Full Text] [Related]
13. Role of cystathionine β-synthase in human breast Cancer.
Sen S; Kawahara B; Gupta D; Tsai R; Khachatryan M; Roy-Chowdhuri S; Bose S; Yoon A; Faull K; Farias-Eisner R; Chaudhuri G
Free Radic Biol Med; 2015 Sep; 86():228-38. PubMed ID: 26051168
[TBL] [Abstract][Full Text] [Related]
14. Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.
Santos I; Ramos C; Mendes C; Sequeira CO; Tomé CS; Fernandes DGH; Mota P; Pires RF; Urso D; Hipólito A; Antunes AMM; Vicente JB; Pereira SA; Bonifácio VDB; Nunes SC; Serpa J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31635026
[TBL] [Abstract][Full Text] [Related]
15. Cystathionine: A novel oncometabolite in human breast cancer.
Sen S; Kawahara B; Mahata SK; Tsai R; Yoon A; Hwang L; Hu-Moore K; Villanueva C; Vajihuddin A; Parameshwar P; You M; Bhaskar DL; Gomez O; Faull KF; Farias-Eisner R; Chaudhuri G
Arch Biochem Biophys; 2016 Aug; 604():95-102. PubMed ID: 27311614
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity.
Bellezza I; Tucci A; Galli F; Grottelli S; Mierla AL; Pilolli F; Minelli A
J Nutr Biochem; 2012 Dec; 23(12):1583-91. PubMed ID: 22444871
[TBL] [Abstract][Full Text] [Related]
17. Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells.
Chen HH; Chang HH; Chang JY; Tang YC; Cheng YC; Lin LM; Cheng SY; Huang CH; Sun MW; Chen CT; Kuo CC
Free Radic Biol Med; 2017 Dec; 113():505-518. PubMed ID: 29080842
[TBL] [Abstract][Full Text] [Related]
18. The novel antioxidant 3-O-caffeoyl-1-methylquinic acid induces Nrf2-dependent phase II detoxifying genes and alters intracellular glutathione redox.
Kweon MH; In Park Y; Sung HC; Mukhtar H
Free Radic Biol Med; 2006 Apr; 40(8):1349-61. PubMed ID: 16631525
[TBL] [Abstract][Full Text] [Related]
19. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.
Brozovic A; Majhen D; Roje V; Mikac N; Jakopec S; Fritz G; Osmak M; Ambriovic-Ristov A
Mol Pharmacol; 2008 Jul; 74(1):298-306. PubMed ID: 18441044
[TBL] [Abstract][Full Text] [Related]
20. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
